Literature DB >> 23152560

Plasmablasts generated during repeated dengue infection are virus glycoprotein-specific and bind to multiple virus serotypes.

Meihui Xu1, Vey Hadinoto, Ramapraba Appanna, Klas Joensson, Ying Xiu Toh, Thavamalar Balakrishnan, Swee Hoe Ong, Lucile Warter, Yee Sin Leo, Cheng-I Wang, Katja Fink.   

Abstract

Dengue virus immune protection is specific to the serotype encountered and is thought to persist throughout one's lifetime. Many serotype cross-reactive memory B cells isolated from humans with previous dengue infection are specific for the nonstructural and the prM structural viral proteins, and they can enhance infection in vitro. However, plasmablasts circulating in enormous numbers during acute secondary infection have not been studied. In this study, we analyzed single plasmablasts from two patients by sorting the cells for Ig sequence analysis and for recombinant expression of Abs. In contrast to memory B cells, most plasmablast-derived Abs bound to the structural E protein of dengue, and protection experiments in mice revealed that virus serotypes encountered during past infections were neutralized more efficiently than were the serotypes of the current infection. Together with genetic analyses, we show evidence that plasmablasts in dengue patients are a polyclonal pool of activated E protein-specific memory B cells and that their specificity is not representative of the serum Abs secreted by long-lived plasma cells in the memory phase. These results contribute to the understanding of the phenomenon of original antigenic sin in dengue.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23152560     DOI: 10.4049/jimmunol.1201688

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

Review 1.  Immune-mediated cytokine storm and its role in severe dengue.

Authors:  Anon Srikiatkhachorn; Anuja Mathew; Alan L Rothman
Journal:  Semin Immunopathol       Date:  2017-04-11       Impact factor: 9.623

2.  Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus.

Authors:  Lalita Priyamvada; Kendra M Quicke; William H Hudson; Nattawat Onlamoon; Jaturong Sewatanon; Srilatha Edupuganti; Kovit Pattanapanyasat; Kulkanya Chokephaibulkit; Mark J Mulligan; Patrick C Wilson; Rafi Ahmed; Mehul S Suthar; Jens Wrammert
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-27       Impact factor: 11.205

3.  Broad and strong: the ultimate antibody to dengue virus.

Authors:  Josefina Coloma; Eva Harris
Journal:  Nat Immunol       Date:  2015-02       Impact factor: 25.606

4.  Detection, phenotyping and quantification of dengue virus-specific B cells using fluorescent probes.

Authors:  Heather Friberg; Anuja Mathew
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

5.  Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.

Authors:  Wen-Yang Tsai; Anna Durbin; Jih-Jin Tsai; Szu-Chia Hsieh; Stephen Whitehead; Wei-Kung Wang
Journal:  J Virol       Date:  2015-07       Impact factor: 5.103

6.  Dengue virus infection induces broadly cross-reactive human IgM antibodies that recognize intact virions in humanized BLT-NSG mice.

Authors:  Smita Jaiswal; Kenneth Smith; Alejandro Ramirez; Marcia Woda; Pamela Pazoles; Leonard D Shultz; Dale L Greiner; Michael A Brehm; Anuja Mathew
Journal:  Exp Biol Med (Maywood)       Date:  2014-08-14

7.  Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine.

Authors:  Diogo M Magnani; Cassia G T Silveira; Michael J Ricciardi; Lucas Gonzalez-Nieto; Núria Pedreño-Lopez; Varian K Bailey; Martin J Gutman; Helen S Maxwell; Aline Domingues; Priscilla R Costa; Lilian Ferrari; Raphaella Goulart; Mauricio A Martins; José M Martinez-Navio; Sebastian P Fuchs; Jorge Kalil; Maria do Carmo Timenetsky; Jens Wrammert; Stephen S Whitehead; Dennis R Burton; Ronald C Desrosiers; Esper G Kallas; David I Watkins
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

8.  Massive plasmablast response elicited in the acute phase of hantavirus pulmonary syndrome.

Authors:  Marina García; Ayelén Iglesias; Verónica I Landoni; Carla Bellomo; Agostina Bruno; María Teresa Córdoba; Luciana Balboa; Gabriela C Fernández; María Del Carmen Sasiain; Valeria P Martínez; Pablo Schierloh
Journal:  Immunology       Date:  2017-02-09       Impact factor: 7.397

9.  Dynamics of Dengue Virus (DENV)-Specific B Cells in the Response to DENV Serotype 1 Infections, Using Flow Cytometry With Labeled Virions.

Authors:  Marcia Woda; Heather Friberg; Jeffrey R Currier; Anon Srikiatkhachorn; Louis R Macareo; Sharone Green; Richard G Jarman; Alan L Rothman; Anuja Mathew
Journal:  J Infect Dis       Date:  2016-07-20       Impact factor: 5.226

10.  Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines.

Authors:  Roland Züst; Ying-Xiu Toh; Iris Valdés; Daniela Cerny; Julia Heinrich; Lisset Hermida; Ernesto Marcos; Gerardo Guillén; Ulrich Kalinke; Pei-Yong Shi; Katja Fink
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.